Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 4, 1998
Issued Date -
N/A
app pub date -
May 24, 1996
filing date -
Aug 14, 1990
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Compositions and methods are provided for inhibiting the translation of a capped target mRNA. Antisense oligomers of the invention are targeted to the 5' cap region of the target mRNA and include oligonucleosides, PNAs, or oligonucleotides modified at the 2' position of the sugar. Preferably said oligomers inhibit protein translation directly via interference with ribosome assembly.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully